ARSG Human

Arylsulfatase G Human Recombinant
Cat. No.
BT23003
Source
Escherichia Coli.
Synonyms
Arylsulfatase G, ASG, ARSG, KIAA1001, UNQ839/PRO1777.
Appearance
Sterile Filtered clear solution.
Purity

Greater than 85% as determined by SDS-PAGE.

Usage

THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Shipped with Ice Packs
In Stock

Description

ARSG Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 532 amino acids (17-525) and having a molecular mass of 57kDa.
ARSG is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Arylsulfatase G (ARSG) is a member of the sulfatase enzyme family responsible for hydrolyzing sulfate esters in various molecules like steroids, carbohydrates, proteoglycans, and glycolipids. These enzymes play crucial roles in hormone biosynthesis, cell signaling modulation, and macromolecule degradation. ARSG specifically exhibits arylsulfatase activity in acidic environments, a characteristic of lysosomal sulfatases. Located within lysosomes, ARSG is inhibited by phosphate, which forms a covalent bond with its active site 3-oxoalanine. Expression of ARSG is widespread in the body, with minimal presence in the brain, lungs, heart, and skeletal muscle.
Description
Recombinant human ARSG, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 532 amino acids (17-525) with a molecular weight of 57kDa. For purification, it is tagged with a 23 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
The ARSG solution is provided at a concentration of 1mg/ml in a buffer containing 20mM Tris-HCl (pH 8.0), 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the ARSG solution should be kept at 4°C. For extended storage, it is recommended to store the solution frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freezing and thawing should be avoided.
Purity
Purity is determined to be greater than 85% using SDS-PAGE analysis.
Synonyms
Arylsulfatase G, ASG, ARSG, KIAA1001, UNQ839/PRO1777.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSGFLYPLV DFCISGKTRG QKPNFVIILA DDMGWGDLGA NWAETKDTAN LDKMASEGMR FVDFHAAAST CSPSRASLLT GRLGLRNGVT RNFAVTSVGG LPLNETTLAE VLQQAGYVTG IIGKWHLGHH GSYHPNFRGF DYYFGIPYSH DMGCTDTPGY NHPPCPACPQ GDGPSRNLQR DCYTDVALPL YENLNIVEQP VNLSSLAQKY AEKATQFIQR ASTSGRPFLL YVALAHMHVP LPVTQLPAAP RGRSLYGAGL WEMDSLVGQI KDKVDHTVKE NTFLWFTGDN GPWAQKCELA GSVGPFTGFW QTRQGGSPAK QTTWEGGHRV PALAYWPGRV PVNVTSTALL SVLDIFPTVV ALAQASLPQG RRFDGVDVSE VLFGRSQPGH RVLFHPNSGA AGEFGALQTV RLERYKAFYI TGGARACDGS TGPELQHKFP LIFNLEDDTA EAVPLERGGA EYQAVLPEVR KVLADVLQDI ANDNISSADY TQDPSVTPCC NPYQIACRCQ AA.

Product Science Overview

Molecular Characteristics

ARSG is synthesized as a 63-kDa single-chain precursor protein that localizes to pre-lysosomal compartments and associates with organelle membranes, most likely the endoplasmic reticulum . Proteolytic processing of ARSG results in fragments of 34-, 18-, and 10-kDa, which are found in lysosomal fractions and lose their membrane association . The processing sites and a disulfide bridge between the 18- and 10-kDa chains have been roughly mapped, with cathepsins B and L identified as the proteases involved . Interestingly, proteolytic processing is dispensable for the enzyme’s hydrolytic activity in vitro .

Expression and Transport

ARSG is differentially expressed, processed, and transported in tissues, involving a membrane-associated pre-lysosomal precursor . The lysosomal transport of ARSG in the liver is independent of mannose 6-phosphate, sortilin, and Limp2 . However, mutation of the glycosylation site N-497 abrogates the transport of ARSG to lysosomes in human fibrosarcoma cells due to impaired mannose 6-phosphate modification .

Clinical Significance

Deficiency of ARSG leads to a new type of mucopolysaccharidosis, as described in a mouse model . This condition is characterized by the accumulation of heparan sulfate due to the inability to degrade 3-O-sulfated N-sulfoglucosamine residues . Understanding the molecular characteristics and transport mechanisms of ARSG is essential for screening and diagnosing ARSG-deficient mucopolysaccharidosis patients .

Recombinant Production

Recombinant human ARSG is produced using various expression systems, including Escherichia coli and Kluyveromyces lactis . These systems allow for the production of ARSG with high purity and activity, making it suitable for research and potential therapeutic applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.